Charles River Laboratories vs WuXi Advanced Therapies

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/criver/wuxi-advanced-therapies

Category	Charles River Laboratories	WuXi Advanced Therapies
Listed site	both	cdmo
Summary	Charles River Laboratories provides contract research, development, and manufacturing services across the full drug discovery and development continuum, supporting 80% of FDA-approved drugs over the past five years.	Cell & gene therapy CDMO offering discovery, process development, analytical development, cell banking, clinical and commercial manufacturing, plus biosafety testing for biologics, mAbs, vaccines, and CGT developers.
Services	CMC Regulatory Submission Support Quality Control Testing Technology Transfer Formulation Development Process Development Cell Therapy Manufacturing Viral Vector Manufacturing Recombinant Protein Manufacturing Monoclonal Antibody (mAb) Manufacturing Biologics Development & Manufacturing API Synthesis & Manufacturing Upstream Processing Downstream Processing CMC Analytical Development Stability Testing & Storage Cell-Line Development Microbial Fermentation Small Molecule Development & Manufacturing AAV Manufacturing Lentiviral Vector Manufacturing Sterile Fill-Finish & Aseptic Manufacturing	Cell Therapy Manufacturing Autologous Cell Therapy Manufacturing Allogeneic Cell Therapy Manufacturing Viral Vector Manufacturing AAV Manufacturing Lentiviral Vector Manufacturing Cell-Line Development Technology Transfer Process Development CMC Analytical Development Stability Testing & Storage Quality Control Testing Vaccine Manufacturing Monoclonal Antibody (mAb) Manufacturing Recombinant Protein Manufacturing
Modalities	Small Molecule Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy AAV / Viral Vector Platform	Biologics (Monoclonal Antibodies) Biologics (Other) Cell Therapy Gene Therapy Vaccine AAV / Viral Vector Platform
Indications	Oncology Immunology Neurology	Data not yet provided.
Locations	Headquarters, United States North America, North America, USA/Canada Europe, Europe, Multiple Asia, Asia, Multiple North America, North America Europe, Europe Asia, Asia	Headquarters, Philadelphia, PA, United States Philadelphia, Philadelphia, PA, United States Allendale, Allendale, NJ, United States Taufkirchen, Taufkirchen, Bavaria, Germany London, London, England, United Kingdom Yokohama, Yokohama, Kanagawa, Japan Manufacturing & Testing, Philadelphia, PA, United States Manufacturing, Allendale, NJ, United States Manufacturing, Taufkirchen, Bavaria, Germany Office, London, England, United Kingdom Manufacturing, Yokohama, Kanagawa, Japan Manufacturing & Testing, Allendale, NJ, United States Manufacturing & Testing, Taufkirchen, Bavaria, Germany Manufacturing & Testing, Yokohama, Kanagawa, Japan
Certifications	FDA · Identifier: 100 IND submissions containing Retrogenix® platform data EMA · Identifier: 100 IND submissions containing Retrogenix® platform data PMDA · Identifier: 100 IND submissions containing Retrogenix® platform data EMA · Identifier: Retrogenix® platform data support PMDA · Identifier: Retrogenix® platform data support	FDA · Identifier: Commercial manufacturing approval EMA · Identifier: Commercial manufacturing approval PMDA · Identifier: Commercial manufacturing approval FDA · Identifier: FDA approval for commercial manufacturing EMA · Identifier: EMA approval for commercial manufacturing PMDA · Identifier: PMDA approval for commercial manufacturing
Reviews	Review summary appears after site-level review signal gate opens.	Review summary appears after site-level review signal gate opens.